GSK’s MenABCWY vaccine is an injectable suspension intended for intramuscular use. It comes with a vial of lyophilised ...
Sciences Division at the University of Oxford, will replace Dr. Jesse Goodman, who retires following nine years of service. Dr. Screaton brings to GSK extensive expertise in immunology and ...
GSK and Immunocore hope the TCRs can prove to ... anticipated to gain approval in late 2017/ early 2018. The privately-held, Oxford-based company says ImmTAC molecules offer a huge competitive ...
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...
GlaxoSmithKline wants to sell more than a ... the heart of the UK's 'golden triangle', extending between London, Oxford and Cambridge, which houses the lion's share of the country's life science ...
Dr. Screaton, currently Head of the Medical (TASE:BLWV) Sciences Division at the University of Oxford, will replace Dr. Jesse Goodman, who retires following nine years of service. Dr. Screaton brings ...
GSK's revenue and EPS exceeded my expectations and those of analysts, thanks to the strong performance of its oncology and HIV franchises. So, Ojjaara/Omjjara sales amounted to $150 million in the ...
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved PENMENVY (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25 ...